This page sets out what national and professional bodies say about acupuncture, condition by condition, with the date and status of each guideline, and how the bodies explain their different conclusions.

Do clinical guidelines recommend acupuncture?

Some do, for some conditions, and bodies reading overlapping sets of trials reach opposite recommendations for the same condition. For chronic low back pain, NICE in England says do not offer it, while the American College of Physicians’ 2017 guideline listed it among the treatments to try first and the World Health Organization says it may be offered. NICE itself says it may be considered for chronic primary pain and to prevent tension-type headache and migraine, and should not be offered for osteoarthritis. Each condition in the table below links to the AcuiQ page that reports the reviews behind it.

Positions by condition

What guideline bodies say about acupuncture, checked October 2026
ConditionBodyPublished and statusPosition on acupuncture
Low back painNICE NG59November 2016; last updated July 2026Do not offer acupuncture for low back pain with or without sciatica.
Low back painAmerican College of PhysiciansFebruary 2017; listed by ACP as inactiveFor chronic pain, one of the treatments to try first (moderate-quality evidence); for acute or subacute pain, one of several options (low-quality evidence). Strong recommendations.
Low back painUS Department of Veterans Affairs and Department of Defense (VA/DoD)2022, version 3.0Suggests acupuncture for chronic low back pain (weak recommendation for); evidence insufficient for acute pain.
Chronic primary low back painWorld Health OrganizationDecember 2023Needling therapies such as acupuncture may be offered as part of care (conditional recommendation, low-certainty evidence).
Chronic primary painNICE NG193April 2021Consider a single course of acupuncture or dry needling, only if delivered in the community, by a healthcare professional at NHS pay band 7 or below, in no more than 5 hours of their time, or at equivalent or lower cost.
OsteoarthritisNICE NG226October 2022Do not offer acupuncture or dry needling.
Osteoarthritis of the knee, hip and handAmerican College of Rheumatology2026 update of the 2019 guideline, summary posted September 2026Conditionally recommends acupuncture; moderate certainty for knee and hip, very low for hand.
Osteoarthritis of the hip and kneeVA/DoD2026, version 3.0Insufficient evidence to recommend for or against acupuncture, acupressure, dry needling or moxibustion.
Chronic tension-type headacheNICE CG150September 2012; last updated June 2025Consider up to 10 sessions over 5 to 8 weeks to prevent attacks.
MigraineNICE CG150September 2012; last updated June 2025Consider up to 10 sessions over 5 to 8 weeks if propranolol, topiramate and amitriptyline have not worked or are unsuitable.
HeadacheVA/DoD2023, version 2.0Insufficient evidence to recommend for or against acupuncture or dry needling.
Irritable bowel syndromeNICE CG61February 2008; last updated April 2017“The use of acupuncture should not be encouraged.”
Chronic constipationAsian Neurogastroenterology and Motility Association and Asia-Pacific Association of GastroenterologyPublished online August 2026Conditional recommendation on moderate-quality evidence: acupuncture may improve symptoms, though differences between trials limit how far the results apply.
Allergic rhinitisAmerican Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS)February 2015Clinicians may offer acupuncture, or refer for it, to patients interested in non-drug treatment.
Acute sore throatNICE NG84January 2018Does not mention acupuncture.
Acute coughNICE NG120February 2019Does not mention acupuncture.
TinnitusNICE NG155March 2020No recommendation on acupuncture.
TinnitusAAO-HNSOctober 2026, replacing the 2014 guidelineAcupuncture statement removed; the 2014 version made no recommendation.
TinnitusVA/DoD2024 (version 1.0)Insufficient evidence to recommend for or against acupuncture.
Chronic tinnitusGerman Society for Otorhinolaryngology (S3)September 2021; review due September 2026, no newer version foundAcupuncture and electroacupuncture should not be used.
Bell’s palsyAAO-HNSNovember 2013; update in developmentNo recommendation on acupuncture.
Primary dysmenorrhoeaNICE Clinical Knowledge SummaryLast revised October 2023Recommends heat and high-frequency TENS as non-drug measures; acupuncture is not among them.
Uterine fibroidsNICE NG88 (heavy menstrual bleeding)March 2018, last updated July 2026Does not mention acupuncture.
Uterine fibroidsSociety of Obstetricians and Gynaecologists of CanadaJune 2025, replacing its earlier guidelineDoes not mention acupuncture.
Pain in labourNICE NG235September 2023; last updated June 2026Do not offer acupuncture or acupressure; support a woman who wants to use them.
Fertility problemsNICE NG257March 2026, replacing CG156Tell people that complementary therapies for fertility problems have not been properly evaluated.
IVFESHRE2023Acupuncture and other complementary therapies are not recommended as add-ons.
Unexplained infertilityESHRE2023Acupuncture in women is probably not recommended (conditional, low-certainty evidence).
Menopausal hot flushesNICE NG23November 2015; last updated April 2026No recommendation on acupuncture.
Menopausal hot flushesNorth American Menopause Society2023, replacing its 2015 statementNot recommended (limited or inconsistent evidence).
Hot flushes after breast cancerSociety for Integrative Oncology2017; endorsed by ASCO in 2018Acupuncture can be considered (grade C).
Nausea and vomiting from chemotherapy, breast cancerSociety for Integrative Oncology2017; endorsed by ASCO in 2018Acupressure and acupuncture recommended.
Cancer painSociety for Integrative Oncology and ASCOSeptember 2022Acupuncture should be recommended for joint pain from aromatase inhibitors; acupuncture, acupressure or reflexology may be recommended for general cancer pain or musculoskeletal pain.
High blood pressureAmerican Heart Association scientific statement2013Not recommended in clinical practice to lower blood pressure (Class III, no benefit).
Atrial fibrillationACC, AHA, ACCP and HRSNovember 2023, replacing the 2014 guideline and its 2019 updateDoes not mention acupuncture.
Atrial fibrillationEuropean Society of Cardiology2024Does not mention acupuncture.
HyperthyroidismAmerican Thyroid AssociationAugust 2016Does not mention acupuncture.
DementiaNICE NG97June 2018; an October 2025 surveillance review of other topics (sleep, mild cognitive impairment, diagnosis) left the recommendations unchangedDo not offer acupuncture to treat dementia.
Chronic insomniaEuropean Sleep Research Society2023, updating its 2017 guidelineNo recommendation on acupuncture.
Chronic insomniaInternational panel of 26 experts from 11 countries, Sleep Medicine ReviewsAugust 2026Electroacupuncture or manual acupuncture may be considered where it is available (conditional, moderate- to low-certainty evidence).
Post-traumatic stress disorderVA/DoD2023, version 4.0Insufficient evidence to recommend for or against acupuncture.

NICE guidelines apply in England, and the VA/DoD guidelines to the US military and veterans’ health systems. WHO’s low back pain guideline is written for primary and community care settings. ESHRE is the European Society of Human Reproduction and Embryology, and ASCO the American Society of Clinical Oncology.

How the bodies reached different conclusions

The guidelines that explain themselves turn on three choices: which comparison counts, whether cost is weighed, and how large a difference has to be to matter.

Which comparison counts

A sham comparison asks whether needling does something beyond the attention, expectation and ritual of treatment; a usual-care comparison asks whether adding acupuncture changes how people fare. The full NICE low back pain guideline of 2016 records that its committee agreed sham-controlled evidence should inform decisions first, and that effects against usual care would count only once an effect against sham had been shown. Against sham, it found no clinical benefit for pain or function, and it recommended against acupuncture.

Five years later, the committee for NICE’s chronic pain guideline found 27 studies showing less pain and better quality of life over three months against usual care or sham, agreed that the benefit over sham indicated a specific effect, and built its cost model on the usual-care trials because they better reflect real-world benefit. NG193 is used alongside NG59 rather than in place of it, so in England acupuncture can be considered for chronic primary pain but not for low back pain.

WHO’s guideline development group weighed both comparisons for chronic primary low back pain: a trivial benefit over sham in the immediate term, and low-certainty evidence of a small benefit to pain and a moderate to large benefit to function against no intervention. It judged the net benefit small and made a conditional recommendation in favour, with a remark that needling should form part of a broader package of care rather than stand alone. Sham acupuncture explains why no sham is inert, and why the bodies can disagree on how to read sham trials.

Whether cost is weighed

NICE weighs cost to the NHS. NG193’s recommendation is hedged by its own economic model: acupuncture was likely to be cost-effective only if delivered in the community, by staff at or below a set pay band, within five hours of their time. For osteoarthritis, the NG226 committee found the evidence, mostly from knee osteoarthritis, showed a lack of benefit and some evidence of harm, and that acupuncture was not cost-effective. It noted very low-quality evidence that electroacupuncture beat sham, and asked for more research on it rather than recommending it. WHO judged the resource implications of acupuncture moderate to large, while noting that in China most people can get it cheaply through insurance subsidies. Cost-effectiveness of acupuncture reports the NICE models and the trial-based evaluations behind them.

How large a difference has to be

The American College of Rheumatology explains its conditional recommendation for osteoarthritis by the size of the difference and the size of the risk. Its 2019 guideline describes acupuncture’s benefit as a large contextual effect plus a small difference between real and sham acupuncture, of the same size as the difference between full-dose paracetamol and placebo, and judged the risk of harm minor. The ACR’s 2026 update kept the conditional recommendation and rated the evidence moderate in certainty for the knee and hip. The VA/DoD osteoarthritis guideline, published the same year, found the evidence insufficient to recommend acupuncture for or against.

Reading a guideline’s date

A guideline’s publication date and its evidence date can differ by years. NICE tags each recommendation with the year its evidence was last reviewed: the labour recommendation in NG235 is marked [2007, amended 2023], meaning its wording changed in 2023 without a new evidence review, and the complementary therapy advice in NG257 is marked [2004] in a guideline published in 2026. The AAO-HNS list of guidelines shows an update of its Bell’s palsy guideline in development; its tinnitus update was published in October 2026, and the VA/DoD numbers each version of a guideline. The American College of Physicians treats any of its guidelines five or more years old as no longer active, and lists its 2017 low back pain guideline among them. The table records the status shown by each body’s own site or journal in October 2026.

What guidelines do not cover

A guideline says whether a treatment should be offered within a health system. It does not say which points, how many sessions or which style of acupuncture, and the trials behind these guidelines varied: WHO’s ranged from one to 40 sessions, and NICE’s chronic pain committee noted wide variation in the type and intensity of acupuncture. A 2025 review in the Bulletin of the World Health Organization found the same gap in headache guidelines: of 25 guidelines, 10 recommended acupuncture for migraine and 8 recommended it conditionally, and 14 of those 18 gave no detail of how to deliver it. AcuiQ indexes the protocols individual studies prescribed, each with its citation, and does not recommend any of them; What AcuiQ does not do sets out that limit.